Edesa Biotech, Inc.
Price Action
Technical Summary
EMERGING TRENDEdesa Biotech, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 99), indicating clear outperformance against the broad market. Earnings contraction of 67% provides fundamental context to the price action. Investors should exercise caution due to high volatility (190% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $6.62 | +15.89% | ABOVE |
| 50 SMA | $9.78 | -21.55% | BELOW |
| 100 SMA | $7.03 | +9.05% | ABOVE |
| 150 SMA | $5.20 | +47.58% | ABOVE |
| 200 SMA | $4.47 | +71.64% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is EDSA in an uptrend right now?
EDSA has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is EDSA overbought or oversold?
EDSA's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is EDSA outperforming the market?
EDSA has a Relative Strength (RS) Rating of 99 out of 99. Yes, EDSA is a market leader, outperforming 99% of all stocks over the past 12 months.
Where is EDSA in its 52-week range?
EDSA is trading at $7.67, which is 38% of its 52-week high ($20.32) and 35% above its 52-week low ($0.72).
How volatile is EDSA?
EDSA has a Beta of -0.46 and 52-week volatility of 190%. It's less volatile than the S&P 500 - generally more stable.